MTAP and urothelial carcinoma: Considering that urothelial carcinomas are often treated by CPIs and that considerable diagnostic difficulties exist in the diagnosis of low‐grade neoplasms/flat dysplasia [25] and in urine cytology [26], immunohistochemical MTAP analysis could also be of diagnostic and predictive value in this tumor type.